For the seven days of Sukkot, the Jewish harvest festival, it hosted guests and family meals. Many observant Jews erect ...

The United States is pressuring Qatar to expel Hamas leaders from its territory due to the terrorist organization’s refusal to consider even a short ceasefire and new suggestions for a hostage release ...

Enrollment and dosing complete in single ascending dose clinical trial of anti-tau antibody VY7523 for Alzheimer's; on track to generate top-line data H1 2025 - - Recent third-party clinical data esta ...

The test leverages a proprietary algorithm to generate an AD score by analyzing five Alzheimer's disease-related biomarkers (p-Tau 217, Aß42/40, NfL, GFAP), offering significantly improved amyloid ...

Researchers uncovered an old monument in Israel, revealing a rare Minoan jug and Canaanite artifacts of ancient religious ...

The Israeli surveillance drone sank in the sky over this embattled city in southern Lebanon, a signal to rescue workers that ...

In addition, I highlighted our recent demonstration of a new assay, for the quantitative measurement of up to 2,048 proteoforms of the protein tau, a protein closely associated with Alzheimer's ...

The scandal became a symbol to the rest of the world of the dangers of unchecked political power. “Nixon’s scandalous downfall was probably another reason for my father to strengthen his robust ...

UCB will ad­vance its an­ti-tau an­ti­body for Alzheimer’s dis­ease so­lo af­ter Roche and Genen­tech walked away from the as­set known as bepranemab.

Roche has returned the rights to UCB’s anti-tau antibody bepranemab, walking away from a $120 million bet on the Alzheimer’s disease drug candidate on the cusp of the release of phase 2a data.